Nanomaterials now have open new ways in diagnostics and treatment of lung diseases. Nanoparticle-based drug delivery systems can help against diseases such as lung cancer, tuberculosis, and pulmonary fibrosis. The diversity in nanotechnology can revolutionize medicine but makes safety assessment really a challenging task. Nanomaterials have an extremely high surface area to volume ratio.
This makes them interesting candidates for novel drugs. Nanotechnology is important for respiratory medicine as it offers new approaches to treating diseases of the respiratory tract. Recent studies have demonstrated that the amount of pulmonary nanoparticle uptake not only depends on physical and chemical nanoparticle characteristics but also on the health status of the organism. An important aspect of assessing the safety of nanotechnology-based products is the absorption of nanoparticles.…
